Assertio Holdings Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Assertio Holdings Inc 公司

Assertio Holdings, Inc. 是一家爲患者提供差異化產品的商業製藥公司。該公司通過收購或授權已獲批准的產品建立了自己的商業組合。其全面的商業能力包括通過銷售團隊和非個人推廣模式進行營銷、通過付款人簽約進入市場以及貿易和分銷。該公司的主要營銷產品包括 ROLVEDONTM（eflapegrastim-xnst）皮下注射劑、INDOCIN（吲哚美辛）栓劑、INDOCIN（吲哚美辛）口服混懸液、Sympazan（氯巴佔）口服膜、Otrexup（甲氨蝶呤）皮下注射劑、SPRIX（酮咯酸氨丁三醇）鼻噴霧劑、CAMBIA（雙氯芬酸鉀口服溶液）和 Zipsor（雙氯芬酸鉀）液體膠囊。 INDOCIN（吲哚美辛）栓劑和 INDOCIN（吲哚美辛）口服混懸液產品是非甾體抗炎藥 (NSAID)。

Assertio Holdings Inc簡介



公司代碼ASRT

公司名稱Assertio Holdings Inc

上市日期Feb 12, 1997

CEOMr. Brendan P. O'Grady

員工數量58

證券類型Ordinary Share

年結日Feb 12

公司地址100 S. Saunders Road

城市LAKE FOREST

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編60045

電話12244197106

網址https://www.assertiotx.com/

公司代碼ASRT

上市日期Feb 12, 1997

CEOMr. Brendan P. O'Grady

Assertio Holdings Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

Executive Vice President, Chief Transformation Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

107.50K

+100.00%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

--

Ms. Heather L. Mason

Independent Chairman of the Board

--

Mr. Sigurd C. (Sig) Kirk

Independent Director

--

Mr. Sravan K. Emany

Independent Director

--

Ms. Mary E Pietryga

Executive Vice President, Chief Commercial Officer

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

Executive Vice President, Chief Transformation Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

107.50K

+100.00%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

--

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

地區USD

名稱

營收

佔比

United States

29.22M

100.00%

業務

地區

業務USD

名稱

營收

佔比

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

股東統計

更新時間: 8月17日週日

持股股東

股東類型

持股股東

佔比

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.56%

Renaissance Technologies LLC

2.93%

BlackRock Institutional Trust Company, N.A.

1.43%

Geode Capital Management, L.L.C.

1.06%

其他

80.87%

持股股東

佔比

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.56%

Renaissance Technologies LLC

2.93%

BlackRock Institutional Trust Company, N.A.

1.43%

Geode Capital Management, L.L.C.

1.06%

其他

80.87%

股東類型

持股股東

佔比

Hedge Fund

14.08%

Investment Advisor

9.33%

Investment Advisor/Hedge Fund

3.41%

Individual Investor

2.61%

Research Firm

0.05%

Venture Capital

0.01%

其他

70.51%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

269

25.82M

26.82%

-22.80M

2025Q2

311

28.52M

29.77%

-30.86M

2025Q1

337

28.16M

29.40%

-32.55M

2024Q4

339

31.00M

32.47%

-30.41M

2024Q3

330

33.06M

34.86%

-33.72M

2024Q2

326

40.98M

43.17%

-33.17M

2024Q1

316

48.96M

52.78%

-20.37M

2023Q4

308

49.49M

53.68%

-10.26M

2023Q3

295

49.25M

53.86%

+8.83M

2023Q2

258

36.71M

65.25%

+1.46M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Nantahala Capital Management, LLC

8.81M

9.15%

+370.31K

+4.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.38M

4.56%

--

Jun 30, 2025

Renaissance Technologies LLC

2.82M

2.93%

+117.69K

+4.35%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

1.37M

1.43%

-11.56K

-0.83%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.02M

1.06%

-86.31K

-7.79%

Jun 30, 2025

Two Sigma Investments, LP

867.90K

0.9%

-357.19K

-29.16%

Jun 30, 2025

CM Management, LLC

724.38K

0.75%

+249.38K

+52.50%

Jun 30, 2025

Millennium Management LLC

694.52K

0.72%

-90.05K

-11.48%

Jun 30, 2025

Polen Capital Management, LLC

651.61K

0.68%

-129.46K

-16.57%

Sep 30, 2024

Peisert (Daniel A)

607.46K

0.63%

--

Mar 13, 2025

持股ETF



更新時間: 7 小時前

機構名稱

佔比

ALPS Barron's 400 ETF

0%

iShares Russell 2000 Value ETF

0%

iShares Russell 2000 ETF

0%

Global X Russell 2000 ETF

0%

Royce Quant Small-Cap Quality Value ETF

0%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0%

Proshares Ultra Russell 2000

0%

Lattice Hartford Multifactor Small Cap ETF

0%

Fidelity Small-Mid Multifactor ETF

0%

iShares Russell 3000 ETF

0%

ALPS Barron's 400 ETF

佔比0%

iShares Russell 2000 Value ETF

佔比0%

iShares Russell 2000 ETF

佔比0%

Global X Russell 2000 ETF

佔比0%

Royce Quant Small-Cap Quality Value ETF

佔比0%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0%

Proshares Ultra Russell 2000

佔比0%

Lattice Hartford Multifactor Small Cap ETF

佔比0%

Fidelity Small-Mid Multifactor ETF

佔比0%

iShares Russell 3000 ETF

佔比0%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

公告日期

類型

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1